2-((3,5-Difluoro-4-Hydroxyphenyl)Amino)-8-Isopentyl-5,7-Dimethyl-7,8-Dihydropteridin-6(5H)-One 2-((3,5-二氟-4-羟基苯基)氨基)-8-异戊基-5,7-二甲基-7,8-二氢蝶啶-6(5H)-酮
CAS 501437-28-1 MFCD11223662
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
产品应用
- BI-D1870 is a potent and specific RSK inhibitor (the p90 ribosomal S6 kinase), which inhibits RSK1, RSK2, RSK3 and RSK4 in vitro with an IC50 of 10–30 nM. BI-D1870 exhibited a dose-responsive antiproliferative effect on OSCC cells with relative sparing of normal human oral keratinocytes. The compound inhibited the downstream RSK target YB-1 and caused apoptosis. In addition, BI-D1870 also induced G2/M arrest by modulating the expression of p21 and other cell cycle regulators. BI-D1870 may be of useful in oral squamous cell carcinoma therapy.